Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Web-only Figures
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watt, A P
Right arrow Articles by Ennis, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watt, A P
Right arrow Articles by Ennis, M
Thorax 2004;59:231-236
© 2004 BMJ Publishing Group Ltd & British Thoracic Society


AIRWAY BIOLOGY

Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis

A P Watt, V Brown, J Courtney, M Kelly, L Garske, J S Elborn, M Ennis

Respiratory Research Group, Centre for Infection, Inflammation and Repair, The Queen’s University of Belfast, Belfast, UK

Correspondence to:
Correspondence to:
Dr A P Watt
Respiratory Research Group, Centre for Infection, Inflammation and Repair, The Queen’s University of Belfast, Belfast, UK; a.watt{at}qub.ac.uk


ABSTRACT
Background: Lower airway secretions from patients with bronchiectasis show inflammatory cell infiltration and increased proinflammatory mediators. The aim of this study was to investigate the effects of antibiotic treatment for exacerbations on neutrophil apoptosis and necrosis.

Methods: Sputum was induced from 15 subjects with idiopathic bronchiectasis at the beginning of an acute exacerbation and after intravenous antibiotic treatment. Neutrophil apoptosis and necrosis were assessed using flow cytometry and morphology and the supernatant was analysed for concentrations of inflammatory mediators.

Results: Neutrophil numbers (x106 cells/g sputum) in sputum were significantly greater on day 0 than on day 14 (median difference (95% confidence interval (CI)) 5.14 (1.27 to 8.46), p = 0.02). Controls had a significantly higher percentage of sputum macrophages than patients with bronchiectasis (day 0, 1.35 (95% CI 0.48 to 2.89), p = 0.004; day 14, 1.09 (95% CI 0.26 to 2.86), p = 0.02). The concentrations of tumour necrosis factor {alpha} (pg/ml), interleukin 8 (ng/ml), and neutrophil elastase (ng/ml) in sputum supernatant were significantly reduced on day 14 compared with day 0 (median difference -94 (95% CI -158 to -27), p = 0.005; -106 (95% CI -189 to -50), p = 0.0006; and -73 451 (95% CI -135 495 to -12 303), p = 0.02 respectively). Patients with bronchiectasis had a significantly lower percentage of cells which were neither apoptotic nor necrotic than healthy controls (both days, -38.8 (95% CI -49.6 to -8.5), p = 0.002; -45.0 (95% CI -58.0 to -34.1), p = 0.0003, respectively), and on day 14 they had a significantly higher percentage of secondary necrotic cells than healthy controls (40 (95% CI 11.6 to 57.5), p = 0.004).

Conclusions: This study shows that antibiotic treatment affects concentrations of proinflammatory mediators and cell death and clearance may be altered in bronchiectasis.


Keywords: induced sputum; inflammation; flow cytometry

Abbreviations: CRP, C reactive protein; FEV1, forced expiratory volume in 1 second; IL, interleukin; NE, neutrophil elastase; TNF{alpha}, tumour necrosis factor {alpha}




This article has been cited by other articles:


Home page
Chronic Respiratory DiseaseHome page
J. Courtney, M. Kelly, A Watt, L Garske, J Bradley, M Ennis, and J. Elborn
Quality of life and inflammation in exacerbations of bronchiectasis
Chronic Respiratory Disease, August 1, 2008; 5(3): 161 - 168.
[Abstract] [PDF]


Home page
ThoraxHome page
A B Chang and D Bilton
Exacerbations in cystic fibrosis: 4 {middle dot} Non-cystic fibrosis bronchiectasis
Thorax, March 1, 2008; 63(3): 269 - 276.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. A. Martinez-Garcia, J.-J. Soler-Cataluna, M. Perpina-Tordera, P. Roman-Sanchez, and J. Soriano
Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis
Chest, November 1, 2007; 132(5): 1565 - 1572.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Rytila, M. Plataki, F. Bucchieri, M. Uddin, G. Nong, V. L. Kinnula, and R. Djukanovic
Airway neutrophilia in COPD is not associated with increased neutrophil survival
Eur. Respir. J., December 1, 2006; 28(6): 1163 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. L. Simpson, R. J. Scott, M. J. Boyle, and P. G. Gibson
Differential Proteolytic Enzyme Activity in Eosinophilic and Neutrophilic Asthma
Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 559 - 565.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A P Watt, J Courtney, J Moore, M Ennis, and J S Elborn
Neutrophil cell death, activation and bacterial infection in cystic fibrosis
Thorax, August 1, 2005; 60(8): 659 - 664.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Teramoto, T. Ishii, H. Yamamoto, Y. Yamaguchi, and Y. Ouchi
Apoptosis of Circulating Neutrophils and Alveolar Macrophages in COPD
Chest, March 1, 2005; 127(3): 1079 - 1080.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & British Thoracic Society